Interestingly, IFN-γ treatment resulted in prolonged type 2 activity in MLN of BALB/c mice, evident in the higher frequencies of GATA-3+ T cells at day 14 p.i. compared to untreated infection controls (Fig. 4E). The gene discussed is GATA3; the disease is infection.